The groundbreaking therapy of the medication represents a exciting advance in the care of the condition. Distinct from existing medications, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatide-peptide163765.bloggerswise.com/50489473/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment